Ticker Launch

IPO · TLIS

Talis Biomedical Corp

Formerly SlipChip Corp

Talis Biomedical Corp (TLIS) priced its initial public offering on Feb 12, 2021 at $16.00 per share, within its $14.00–$16.00 range, raising $220.8M, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $853.5M. Cooley advised the company and Latham & Watkins advised the underwriters.

Status
IPO
Ticker
TLIS
Exchange
Nasdaq Global Market
Priced
Feb 12, 2021
IPO price
$16.00
Price range
$14.00–$16.00
Raised
$220.8M
Market cap at IPO price
$853.5M
First filed
Jan 22, 2021
Company counsel
Cooley
Underwriters' counsel
Latham & Watkins
Sector
Industrials & materials
Country / state
IL

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.

More on this listing for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Then $99/month or $999/year. Cancel anytime.

Filings

Other Industrials & materials IPOs in 2021